This is a StreetInsider.com Premium Only Page

Marinus Pharma (MRNS) –

Apr 19, 2024 06:05 AM Form SC 13G MARINUS PHARMACEUTICALS, Filed by: TANG CAPITAL PARTNERS LP

Apr 17, 2024 10:54 AM Marinus Pharmaceuticals (MRNS) PT Lowered to $10 at Truist Securities

Apr 16, 2024 06:31 AM Marinus Pharmaceuticals (MRNS) PT Lowered to $13 at Cantor Fitzgerald

Apr 16, 2024 04:40 AM Baird Downgrades Marinus Pharmaceuticals (MRNS) to Neutral, 'Phase 3 RAISE Study Doesn't Hit at Interim'

Apr 15, 2024 12:54 PM RBC Capital Downgrades Marinus Pharmaceuticals (MRNS) to Sector Perform

Apr 15, 2024 12:53 PM Marinus Pharmaceuticals (MRNS) PT Lowered to $4 at Ladenburg Thalmann

Apr 15, 2024 07:32 AM Form 8-K MARINUS PHARMACEUTICALS, For: Apr 15

Apr 15, 2024 07:01 AM Marinus Pharma (MRNS) phase 3 RAISE trial did not meet pre-defined stopping criteria at the interim analysis

Apr 15, 2024 07:00 AM Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results

Apr 15, 2024 06:55 AM Marinus Pharma (MRNS) Halted, News Pending

Apr 5, 2024 04:00 PM Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Apr 4, 2024 08:03 AM Form DEFA14A MARINUS PHARMACEUTICALS,

Apr 4, 2024 08:00 AM Form DEF 14A MARINUS PHARMACEUTICALS, For: May 22

Mar 28, 2024 03:28 PM Oppenheimer Reiterates Perform Rating on Marinus Pharmaceuticals (MRNS)

Mar 27, 2024 04:06 PM Form 8-K MARINUS PHARMACEUTICALS, For: Mar 27

Mar 27, 2024 11:55 AM Form 4 MARINUS PHARMACEUTICALS, For: Mar 27 Filed by: Braunstein Scott

Mar 27, 2024 08:41 AM Marinus Pharma (MRNS) Comments on Patent Challenge by Ovid, Provides Update on Marinus’ Post Grant Review

Mar 27, 2024 08:41 AM Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review

Mar 19, 2024 04:15 PM DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results

Mar 5, 2024 04:15 PM Form 10-K MARINUS PHARMACEUTICALS, For: Dec 31

Mar 5, 2024 04:06 PM Form 8-K MARINUS PHARMACEUTICALS, For: Mar 05

Mar 5, 2024 04:05 PM Marinus Pharma (MRNS) Misses Q4 EPS by 12c ; Offers Guidance

Mar 5, 2024 04:01 PM Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 22, 2024 04:06 PM Form 4 MARINUS PHARMACEUTICALS, For: Feb 20 Filed by: Shafer Christina

Feb 22, 2024 04:06 PM Form 4 MARINUS PHARMACEUTICALS, For: Feb 20 Filed by: MANNING MARTHA E

Feb 21, 2024 04:06 PM Form 4 MARINUS PHARMACEUTICALS, For: Feb 16 Filed by: Hulihan Joseph

Feb 21, 2024 04:06 PM Form 4 MARINUS PHARMACEUTICALS, For: Feb 16 Filed by: Pfanstiel Steven

Feb 21, 2024 04:05 PM Form 4 MARINUS PHARMACEUTICALS, For: Feb 16 Filed by: Braunstein Scott

Feb 21, 2024 07:00 AM Marinus Pharmaceuticals to Present at Upcoming Investor Conferences

Feb 20, 2024 07:00 AM Marinus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

Feb 16, 2024 04:00 PM Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Feb 14, 2024 04:19 PM Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: Lion Point Capital, LP

Feb 14, 2024 03:07 PM Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: Cormorant Asset Management, LP

Feb 14, 2024 12:18 PM Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: EVENTIDE ASSET MANAGEMENT, LLC

Feb 14, 2024 10:36 AM Form SC 13G MARINUS PHARMACEUTICALS, Filed by: PRUDENTIAL FINANCIAL INC

Feb 14, 2024 10:08 AM Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: Point72 Asset Management, L.P.

Feb 14, 2024 09:04 AM Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: Avoro Capital Advisors LLC

Feb 13, 2024 12:13 PM Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC

Feb 8, 2024 01:57 PM Form SC 13G MARINUS PHARMACEUTICALS, Filed by: JENNISON ASSOCIATES LLC

Feb 7, 2024 07:25 AM Form SC 13G/A MARINUS PHARMACEUTICALS, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.

Feb 6, 2024 11:58 AM Form SC 13G MARINUS PHARMACEUTICALS, Filed by: FRANKLIN RESOURCES INC

Jan 25, 2024 05:00 PM Form SC 13G MARINUS PHARMACEUTICALS, Filed by: BlackRock Inc.

Jan 22, 2024 08:23 AM DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer

Jan 19, 2024 04:29 PM Form 4 MARINUS PHARMACEUTICALS, For: Jan 18 Filed by: Noonberg Sarah B.

Jan 19, 2024 04:28 PM Form 4 MARINUS PHARMACEUTICALS, For: Jan 18 Filed by: Johnson Marvin

Jan 19, 2024 04:27 PM Form 4 MARINUS PHARMACEUTICALS, For: Jan 18 Filed by: Silverstein Christine Berni

Jan 19, 2024 04:27 PM Form 4 MARINUS PHARMACEUTICALS, For: Jan 18 Filed by: Ezickson Elan

Jan 19, 2024 04:25 PM Form 4 MARINUS PHARMACEUTICALS, For: Jan 18 Filed by: Fischer Seth H. Z.

Jan 19, 2024 04:24 PM Form 4 MARINUS PHARMACEUTICALS, For: Jan 18 Filed by: Nochur Sara

Jan 19, 2024 04:23 PM Form 4 MARINUS PHARMACEUTICALS, For: Jan 18 Filed by: Austin Charles